Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
Go back to Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.84 +0.23 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.61 | 52 Week High | $77.12 | |||
| Open | $63.49 | 52 Week Low | $49.03 | |||
| Day High | $64.00 | P/E | 41.45 | |||
| Day Low | $63.00 | EPS | $1.54 | |||
| Volume | 4,647,749 | |||||
